MedPath

Effect of Platelet-rich plasma treatment of male pattern baldness

Not Applicable
Conditions
Androgenetic Alopecia.
Androgenic alopecia, unspecified
Registration Number
IRCT2013072814190N1
Lead Sponsor
Ahwaz Jundishapur University of Medical Sciences, Vice Chancellor for Research and technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
19
Inclusion Criteria

androgenetic alopecia according to the following scales: men: Hamilton/Norwood Scale: grades Va- VII and possibility of follow-up during the study.
Exclusion criteria:active inflammation or infection in the intervention area; presence of active systemic infections; background of cancerous or precancerous lesions; suffering from any serious blood disorders; to have undergone treatments for alopecia in the previous 6 months; previous hair implants; intake of drugs that affect hair loss; be undergoing immunosuppressive therapy and/or anticoagulants.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline in Hair density. Timepoint: 6 month. Method of measurement: Hair density (number of hairs per cm2) will be measured for each case.
Secondary Outcome Measures
NameTimeMethod
Infection. Timepoint: 1 weak after Injection. Method of measurement: Clinical.
© Copyright 2025. All Rights Reserved by MedPath